文献速递乳腺癌放疗放疗物理与技术

降低钆基对比剂剂量用于DCE-MRI引导的SBRT:对早期乳腺癌患者术前靶区勾画观察者间和观察者内变异性的影响

Reducing the dose of gadolinium-based contrast agents for DCE-MRI guided SBRT: The effects on inter and intra observer variability for preoperative target volume delineation in early stage breast cancer patients.
PubMed 文献 · Radiother Oncol · 2018-12-29

本研究纳入23例接受新辅助放疗的早期乳腺癌患者,5名观察者基于DCE-MRI勾画GTV,其中14/23例接受全临床剂量对比剂、9/23例接受半剂量。结果显示两组勾画体积无显著差异,全剂量组观察者间变异性更大,降低对比剂剂量未显著改变观察者间或观察者内变异性。

要点

  • 半剂量对比剂组GTV和CTV中位体积分别低0.26 cm3和1.27 cm3,但差异无统计学显著。
  • 全剂量对比剂组观察者间变异性更大,可能因全剂量对比剂使周边强化更明显。
  • 降低对比剂剂量未显著改变观察者间或观察者内变异性。

核心结论

  • 降低对比剂剂量未显著改变观察者间或观察者内变异性。
  • 上述结果促使本中心减少SIGNAL试验所有入组患者的钆剂量。

研究设计与样本

  • 本研究纳入23例接受新辅助放疗的早期乳腺癌患者,5名观察者基于DCE-MRI勾画GTV。
  • 14/23例患者接受全临床剂量对比剂,9/23例接受半剂量对比剂。
  • 通过0.5 cm均匀外扩生成CTV,采用勾画体积差异和可靠性系数等指标量化观察者间和观察者内可靠性。

主要发现

  • 两组勾画体积无显著差异,但半剂量对比剂组GTV和CTV中位体积分别低0.26 cm3和1.27 cm3。
  • 两个剂量组观察者间和观察者内均显示高度一致性。
  • 全剂量对比剂组观察者间变异性更大,最可能因全剂量对比剂使周边强化更明显。

临床怎么用

  • 本中心的做法是减少SIGNAL试验所有入组患者的钆剂量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: This study aimed to determine the effects of reducing the dose of contrast agent (CA) in a DCE-MRI scan on inter- and intra-observer variability in the context of MRI-guided target volume delineation for stereotactic body radiation therapy of early stage breast cancer patients. This is in hopes of reducing risks to patients due to findings of residual CA in brain and bone. MATERIALS AND METHODS: Twenty-three patients receiving neoadjuvant radiation therapy were enrolled. Five observers delineated the gross target volume (GTV) using DCE-MRI for guidance. 14/23 patients received the full clinical dose of CA and 9/23 received half. Clinical target volumes (CTV) were created through a 0.5 cm uniform expansion. Several metrics were used to quantify the inter and intra-observer reliability including differences in delineation volume and the reliability coefficient. RESULTS: There were no significant differences in the volume, though half contrast patients had a lower median for both the GTV and CTV (difference of 0.26 cm3 and 1.27 cm3, respectively). All indicated a high degree of agreement between and within observers for both dose groups. However, the full dose group had a greater inter-observer variability, most likely due to the full CA causing more pronounced enhancement in the periphery. CONCLUSIONS: Reducing the dose of contrast agent did not significantly alter inter- or intra-observer variability. These results have prompted our centre to reduce the dose of gadolinium in all patients enrolled in the SIGNAL trial.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Mouawad M, Biernaski H, Brackstone M, et al. Reducing the dose of gadolinium-based contrast agents for DCE-MRI guided SBRT: The effects on inter and intra observer variability for preoperative target volume delineation in early stage breast cancer patients. Radiother Oncol. 2018. PMID: 30773188. doi:10.1016/j.radonc.2018.11.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。